https://www.healthcaremea.com/2026/04/16/eli-lilly-to-acquire-crossbridge-bio-in-usd300m-deal-to-advance-next-generation-cancer-therapies/
Eli Lilly to acquire CrossBridge Bio in USD300M deal to advance next-generation cancer therapies |...
Apr 16, 2026 - CrossBridge Bio plans to submit an Investigational New Drug (IND) application for CBB-120, positioning the candidate for clinical development.